The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
about
Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics toolspH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic AgentsCationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.Komodo dragon-inspired synthetic peptide DRGN-1 promotes wound-healing of a mixed-biofilm infected woundIdentification of Mycobacterium avium genes associated with resistance to host antimicrobial peptides.LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalentsAntimicrobial peptides and wound healing: biological and therapeutic considerationsInactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coliShort, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics.Carbamylated LL-37 as a modulator of the immune response.Identification of Human Cathelicidin Peptide LL-37 as a Ligand for Macrophage Integrin αMβ2 (Mac-1, CD11b/CD18) that Promotes Phagocytosis by Opsonizing Bacteria.LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells.The role of biophysical parameters in the antilipopolysaccharide activities of antimicrobial peptides from marine fish.Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized therapeutic activity.Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties.Therapeutic utility of antibacterial peptides in wound healing.Unique features of human cathelicidin LL-37.Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns.P2X7 Receptor Regulates Internalization of Antimicrobial Peptide LL-37 by Human Macrophages That Promotes Intracellular Pathogen Clearance.LL37 peptide@silver nanoparticles: combining the best of the two worlds for skin infection control.Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia.Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing.Antimicrobial peptide LL-37 promotes antigen-specific immune responses in mice by enhancing Th17-skewed mucosal and systemic immunities.Effects of conditioned medium from LL-37 treated adipose stem cells on human fibroblast migration.Antifungal nanofibers made by controlled release of sea animal derived peptide.The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens.Plasma treatments of dressings for wound healing: a review.Wound-Healing Peptides for Treatment of Chronic Diabetic Foot Ulcers and Other Infected Skin Injuries.Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers.Adding Functions to Biomaterial Surfaces through Protein Incorporation.
P2860
Q26997004-DAB3F2A9-E7F7-4999-86B0-9C29E52176C7Q28070241-4FB04230-B6DF-4B5D-9098-56FBF06605C8Q30151971-63F54F33-B1E4-4494-8984-2C928668DF17Q33731274-8C6C7B1B-3E61-421B-B6AC-A03F46B3197AQ33781238-995D8E22-7E85-4A90-81A5-95F1AC705187Q34058299-4E838BF5-9521-4523-B0EC-DCD4430BB16BQ34507671-2015ED92-017E-4ADA-89AC-FFE1D5199E7EQ35609334-559F948F-35DA-48E1-B860-99E9B266DE7FQ36439097-BC3A7892-A319-49AE-8DB7-7F4E92F54E58Q36683469-0850BC53-B24A-45B7-B074-2493B3A5826BQ37483146-2FCA7A21-0003-42F7-B7D7-840C80F3D8FBQ37505380-F600D71B-57DA-4497-ADEB-F0AA62CFF86EQ37547116-91BFC05F-D685-401D-962C-DEB0463CCF4CQ37667006-2F503A09-7609-443F-B103-B342DC6FEB74Q37712921-B857C921-F097-41EB-A96F-B9E64EE43D2EQ38285790-5CAA84B0-CD64-41A4-AD29-7484C39142B5Q38401924-7AE27CBF-AAEB-4D88-9011-024C8977AAC0Q38598753-5B491F2B-3320-48B1-899B-2C8DA81B40A9Q38693024-BBE399AC-D4C8-4F7C-8C65-2EBB94054C3FQ38859591-68F9413E-B3DF-4EE1-9ECF-CD289C26E212Q38999330-A8DF7EBE-6C53-418E-94B4-AB10EE77F7A0Q40099608-4A4E3A72-7483-4511-9D4D-3C5C17ADFE4BQ40104332-E71793C2-4635-441F-822A-9D9C60869078Q40170667-A4E6050E-2726-4CC4-94EC-8BDBD8EAF062Q41016158-E68207AA-ABE6-4075-A217-BC371F1C066BQ41209461-4D1DDE2F-A64A-41D0-9D0E-F91988C4148AQ47104073-D7B75254-7650-4AF0-805B-CD2D1D8D75A1Q47143944-49A0575D-AFD1-4521-9AA3-B39162520351Q48149164-5D8D05AC-0C8F-4F1D-AB3F-F74EBC506D23Q52691175-860ADA63-E9FA-4FAE-B9F0-A270D8B457A7Q53100671-CBF0C72B-B1C8-44D6-A8D2-5594492731EA
P2860
The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The Human Cathelicidin Antimic ...... Polymicrobial Infected Wounds
@en
type
label
The Human Cathelicidin Antimic ...... Polymicrobial Infected Wounds
@en
prefLabel
The Human Cathelicidin Antimic ...... Polymicrobial Infected Wounds
@en
P2860
P356
P1476
The Human Cathelicidin Antimic ...... Polymicrobial Infected Wounds
@en
P2093
Allen J Duplantier
P2860
P356
10.3389/FIMMU.2013.00143
P577
2013-07-03T00:00:00Z